Hyundai Bioscience

048410.KQ

4.91 USD

0.10

+2.08%

Overview

Last close

4.91 usd

Market cap

474.18M usd

52 week high

13.86 usd

52 week low

3.13 usd

Target price

N/A usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

197.9038

Price/Book Value

6.3616

Enterprise Value

460.58M usd

EV/Revenue

191.9471

EV/EBITDA

-64.6317

Key financials

Revenue TTM

2.40M usd

Gross Profit TTM

-181106.41 usd

EBITDA TTM

-12.91M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

84.85M usd

Net debt

2.74M usd

About

Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.